Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (5y) (2014 - 2026)
Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.05% |
| Dec 31, 2025 | -1.00% |
| Sep 30, 2025 | 52.93% |
| Jun 30, 2025 | 3.94% |
| Mar 31, 2025 | 8.41% |
| Dec 31, 2024 | 9.91% |
| Sep 30, 2024 | 18.30% |
| Jun 30, 2024 | 13.46% |
| Mar 31, 2024 | 11.01% |
| Dec 31, 2023 | 8.38% |
| Sep 30, 2023 | 19.73% |
| Jun 30, 2023 | 20.97% |
| Mar 31, 2023 | 17.19% |
| Dec 31, 2022 | 24.85% |
| Sep 30, 2022 | 8.68% |
| Jun 30, 2022 | 82.89% |
| Mar 31, 2022 | 42.64% |
| Dec 31, 2021 | 43.46% |
| Sep 30, 2021 | 39.29% |
| Jun 30, 2021 | 9.42% |